Texas on Thursday became the latest state to take insulin manufacturers and the top entities managing prescription drug benefits to court over allegations that the companies have conspired to artificially raise the price of diabetes medications.
The lawsuit from Texas Attorney General Ken Paxton (R) filed in Texas District Court, Travis County, includes allegations that insulin manufacturers